Matches in SemOpenAlex for { <https://semopenalex.org/work/W4200352202> ?p ?o ?g. }
- W4200352202 endingPage "138" @default.
- W4200352202 startingPage "137" @default.
- W4200352202 abstract "Abstract We evaluated invasive pneumococcal disease (IPD) during 8 years of infant pneumococcal conjugate vaccine (PCV) programs using 10-valent (PCV10) and 13-valent (PCV13) vaccines in 10 countries in Europe. IPD incidence declined during 2011–2014 but increased during 2015–2018 in all age groups. From the 7-valent PCV period to 2018, IPD incidence declined by 42% in children <5 years of age, 32% in persons 5–64 years of age, and 7% in persons >65 years of age; non-PCV13 serotype incidence increased by 111%, 63%, and 84%, respectively, for these groups. Trends were similar in countries using PCV13 or PCV10, despite different serotype distribution. Serotypes included in the 15-valent PCV represented one third of cases and those in the 20-valent PCVs two thirds of cases in children <5 years of age and in persons >65 years of age in 2018. Non-PCV13 serotype increases reduced the overall effect of childhood PCV10/PCV13 programs on IPD. New vaccines providing broader serotype protection are needed." @default.
- W4200352202 created "2021-12-31" @default.
- W4200352202 creator A5001448896 @default.
- W4200352202 creator A5006189641 @default.
- W4200352202 creator A5006751480 @default.
- W4200352202 creator A5009233199 @default.
- W4200352202 creator A5011135869 @default.
- W4200352202 creator A5013910120 @default.
- W4200352202 creator A5019717829 @default.
- W4200352202 creator A5022913231 @default.
- W4200352202 creator A5025719086 @default.
- W4200352202 creator A5032587901 @default.
- W4200352202 creator A5033248082 @default.
- W4200352202 creator A5043049042 @default.
- W4200352202 creator A5045650593 @default.
- W4200352202 creator A5046888535 @default.
- W4200352202 creator A5047245688 @default.
- W4200352202 creator A5048995332 @default.
- W4200352202 creator A5055258674 @default.
- W4200352202 creator A5061575770 @default.
- W4200352202 creator A5063210587 @default.
- W4200352202 creator A5063916952 @default.
- W4200352202 creator A5065036763 @default.
- W4200352202 creator A5070755300 @default.
- W4200352202 creator A5070979689 @default.
- W4200352202 creator A5074263116 @default.
- W4200352202 creator A5075178285 @default.
- W4200352202 creator A5083367434 @default.
- W4200352202 creator A5083435393 @default.
- W4200352202 creator A5084640656 @default.
- W4200352202 creator A5085842901 @default.
- W4200352202 creator A5091853424 @default.
- W4200352202 creator A9999999999 @default.
- W4200352202 date "2022-01-01" @default.
- W4200352202 modified "2023-10-17" @default.
- W4200352202 title "Serotype Replacement after Introduction of 10-Valent and 13-Valent Pneumococcal Conjugate Vaccines in 10 Countries, Europe" @default.
- W4200352202 cites W1973914781 @default.
- W4200352202 cites W1997889941 @default.
- W4200352202 cites W2030559542 @default.
- W4200352202 cites W2037321050 @default.
- W4200352202 cites W2093931806 @default.
- W4200352202 cites W2150562212 @default.
- W4200352202 cites W2157583453 @default.
- W4200352202 cites W2237208256 @default.
- W4200352202 cites W2285890775 @default.
- W4200352202 cites W2295071514 @default.
- W4200352202 cites W2559766601 @default.
- W4200352202 cites W2569307502 @default.
- W4200352202 cites W2598501469 @default.
- W4200352202 cites W2624731467 @default.
- W4200352202 cites W2735385734 @default.
- W4200352202 cites W2744487426 @default.
- W4200352202 cites W2772238222 @default.
- W4200352202 cites W2772756703 @default.
- W4200352202 cites W2775739564 @default.
- W4200352202 cites W2784744055 @default.
- W4200352202 cites W2898481824 @default.
- W4200352202 cites W2909509146 @default.
- W4200352202 cites W2912278099 @default.
- W4200352202 cites W2954614311 @default.
- W4200352202 cites W2955621975 @default.
- W4200352202 cites W2964469325 @default.
- W4200352202 cites W2968027080 @default.
- W4200352202 cites W2971512242 @default.
- W4200352202 cites W2981984012 @default.
- W4200352202 cites W2986087392 @default.
- W4200352202 cites W2990546013 @default.
- W4200352202 cites W2990722858 @default.
- W4200352202 cites W2999390456 @default.
- W4200352202 cites W3024114421 @default.
- W4200352202 cites W827260252 @default.
- W4200352202 doi "https://doi.org/10.3201/eid2801.210734" @default.
- W4200352202 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34932457" @default.
- W4200352202 hasPublicationYear "2022" @default.
- W4200352202 type Work @default.
- W4200352202 citedByCount "38" @default.
- W4200352202 countsByYear W42003522022022 @default.
- W4200352202 countsByYear W42003522022023 @default.
- W4200352202 crossrefType "journal-article" @default.
- W4200352202 hasAuthorship W4200352202A5001448896 @default.
- W4200352202 hasAuthorship W4200352202A5006189641 @default.
- W4200352202 hasAuthorship W4200352202A5006751480 @default.
- W4200352202 hasAuthorship W4200352202A5009233199 @default.
- W4200352202 hasAuthorship W4200352202A5011135869 @default.
- W4200352202 hasAuthorship W4200352202A5013910120 @default.
- W4200352202 hasAuthorship W4200352202A5019717829 @default.
- W4200352202 hasAuthorship W4200352202A5022913231 @default.
- W4200352202 hasAuthorship W4200352202A5025719086 @default.
- W4200352202 hasAuthorship W4200352202A5032587901 @default.
- W4200352202 hasAuthorship W4200352202A5033248082 @default.
- W4200352202 hasAuthorship W4200352202A5043049042 @default.
- W4200352202 hasAuthorship W4200352202A5045650593 @default.
- W4200352202 hasAuthorship W4200352202A5046888535 @default.
- W4200352202 hasAuthorship W4200352202A5047245688 @default.
- W4200352202 hasAuthorship W4200352202A5048995332 @default.
- W4200352202 hasAuthorship W4200352202A5055258674 @default.
- W4200352202 hasAuthorship W4200352202A5061575770 @default.
- W4200352202 hasAuthorship W4200352202A5063210587 @default.